July 2013 Editor's Picks: Products from Honeywell and PTI - Pharmaceutical Technology

Latest Issue
PharmTech

Latest Issue
PharmTech Europe

July 2013 Editor's Picks: Products from Honeywell and PTI

Equipment and Processing Report

Featured products from Pharmaceutical Technology's monthly newsletter, Equipment & Processing Report

Honeywell
Software helps operators better manage manufacturing systems.

Software from Honeywell is designed to improve operational excellence by helping plant workers redefine how they maintain system uptime and reliability while providing safer operations. The Intuition Operations Monitoring software, built on Honeywell’s Intuition platform, is used to help operators keep the process within the best operating zone.  The Control Performance Monitoring software helps engineers to monitor, identify, diagnose, and remedy process-control asset issues across all plant layers.  Honeywell’s latest Alarm Management software helps operators better manage their processes without compromising safe operations.


Pharma Technology Inc.
Tablet deduster line offers high-containment with wash-in-place or wash-offline models.

Pharma Technology Inc. (PTI) added high-containment, dust-tight models; wash-in-place (WIP) models; and wash-offline (WOL) models to its PharmFlex line of dedusters. The new models can be used in PTI’s All-In-One (AIO) Tablet Deduster and Tester System. The high-containment, dust-tight model features pinch valves on the tablet inlet, air inlet, and dust extraction ports, as well as PTI’s FlexConnect dust-tight connection, which utilizes FDA-accepted silicone rimming that mates with circular ribs on the inlet and outlet ports. The model includes a pressure-decay test system integrated into the startup routine to ensure full containment and continuous negative-pressure monitoring during operation. The high-containment model is also available as a WIP or WOL model.

ADVERTISEMENT

blog comments powered by Disqus
LCGC E-mail Newsletters

Subscribe: Click to learn more about the newsletter
| Weekly
| Monthly
|Monthly
| Weekly

Survey
What role should the US government play in the current Ebola outbreak?
Finance development of drugs to treat/prevent disease.
Oversee medical treatment of patients in the US.
Provide treatment for patients globally.
All of the above.
No government involvement in patient treatment or drug development.
Finance development of drugs to treat/prevent disease.
27%
Oversee medical treatment of patients in the US.
14%
Provide treatment for patients globally.
8%
All of the above.
41%
No government involvement in patient treatment or drug development.
11%
Jim Miller Outsourcing Outlook Jim MillerCMO Industry Thins Out
Cynthia Challener, PhD Ingredients Insider Cynthia ChallenerFluorination Remains Key Challenge in API Synthesis
Marilyn E. Morris Guest EditorialMarilyn E. MorrisBolstering Graduate Education and Research Programs
Jill Wechsler Regulatory Watch Jill Wechsler Biopharma Manufacturers Respond to Ebola Crisis
Sean Milmo European Regulatory WatchSean MilmoHarmonizing Marketing Approval of Generic Drugs in Europe
FDA Reorganization to Promote Drug Quality
FDA Readies Quality Metrics Measures
New FDA Team to Spur Modern Drug Manufacturing
From Generics to Supergenerics
CMOs and the Track-and-Trace Race: Are You Engaged Yet?
Source: Equipment and Processing Report,
Click here